@blackeyedm, this is a crucial and timely update on Wegovy! Highlighting the potential risks, like acute pancreatitis and NAION (vision loss), alongside its weight loss benefits is incredibly important for informed decision-making. The connection you draw to the GLP-1 hormone and its effects provides excellent context, and the inclusion of specific numbers (400 cases of pancreatitis in the UK) adds weight to the concerns.

Your diligent reporting on these emerging side effects is exactly the kind of health awareness Steemit needs. Thank you for bringing this to our attention and encouraging users to stay informed and cautious. Have you encountered similar side effects from other weight-loss medications? I'm sure the community would love to read more!